ADVANCED PHARMACOLOGY FOR
yy yy yy
PRESCRIBERS 1ST EDITION BY LUO
yy yy yy yy yy
KAYINGO TEST BANK | 2024 UPDATE
yy yy yy yy yy yy
, Table of Contents V
yy V
yy
Chapter V 1: VAn VIntroduction Vto VEvidence-Based VClinical V Practice VGuidelines............................... 3
yy yy yy yy yy yy yy yy
Chapter V2: VPharmacokinetics V /Chapter3: VPharmacodynamics ............................................................. 13
yy yy yy yy
Chapter4: VPharmacogenetics V and VPharmacogenomics .......................................................................... 25
yy yy yy
Chapter V 5: VPharmacology VAcross Vthe VLife VSpan .............................................................................. 30
yy yy yy yy yy yy
Chapter V6: VDrug-Therapy VPrescribing Vin VSpecial VPopulations ......................................................... 36
yy yy yy yy yy yy
Chapter V7: VDrug VDevelopment V and VApproval .................................................................................... 45
yy yy yy yy yy
Chapter V8-Chapter V10: VFoundations Vof VPrescription VWriting VChapter V9: VResponsibleControlled-
yy yy yy yy yy yy yy yy yy
Substance VPrescribing VChapter V10: VAntibiotic VStewardship ................................................................. 51
yy yy yy yy yy
Chapter V11: VApplied VCalculations Vfor V Prescribing ............................................................................ 58
yy yy yy yy yy
Chapter V12-: VPromoting VAdherence VWith VPharmacotherapy VII: VSystem-Specific Vand VPatient-
yy yy yy yy yy yy yy yy yy
Focused VPrescribing VChapter V13: VPharmacotherapy Vfor VEar, VNose, VMouth, VandThroat VConditions
yy yy yy yy yy yy yy yy yy yy
V/Chapter V14: VPharmacotherapy Vfor VEye VConditions ........................................................................... 67
yy yy yy yy yy yy
Chapter V15: VPharmacotherapy Vfor V Skin VConditions .......................................................................... 74
yy yy yy yy yy
Chapter V 16: VPharmacotherapy Vfor V Neurologic V Conditions................................................................ 81
yy yy yy yy yy
Chapter V 17: VPharmacotherapy Vfor V Cardiovascular V Conditions ......................................................... 94
yy yy yy yy yy
Chapter V 18: VPharmacotherapy Vfor V Respiratory VConditions ............................................................. 106
yy yy yy yy yy
Chapter V19: VPharmacotherapy Vfor VGastrointestinal VConditions Vand VConditions
yy yy yy yy yy yy yy
VRequiringNutritional VSupport ................................................................................................................ 117
yy yy
Chapter V 20: VPharmacotherapy Vfor V Genitourinary VConditions.......................................................... 128
yy yy yy yy yy
Chapter V21: VPharmacotherapy Vfor V Renal, VAcid–Base, V Fluid, Vand VElectrolyte VDisorders ......... 133
yy yy yy yy yy yy yy yy yy
Chapter V 22: VPharmacotherapy Vfor VMusculoskeletal Vand VRheumatologic VConditions ................. 146
yy yy yy yy yy yy yy
Chapter V23: VTherapeutic V Applications V of VImmunology Vand VVaccines ....................................... 158
yy yy yy yy yy yy yy
Chapter V 24: VPharmacotherapy Vfor V Endocrine VDisorders ................................................................. 163
yy yy yy yy yy
Chapter V25: VPharmacotherapy Vfor VHematologic VDisorders .............................................................. 174
yy yy yy yy yy
Chapter V 26: VHematology/Oncology Vand VSupportive V Care Vfor Vthe VNononcologist ..................... 190
yy yy yy yy yy yy yy yy
Chapter yy V 27: VPharmacotherapy V Related Vto VWomen’s VHealth VConditions .................................... 196
yy yy yy yy yy yy
Chapter V28: VPharmacotherapy VRelated Vto VMen’s V Health VConditions........................................... 211
yy yy yy yy yy yy yy
Chapter V 29: VPharmacotherapy VRelated Vto VTransgender V Care ....................................................... 217
yy yy yy yy yy yy
Chapter V30: VAntimicrobial VPharmacotherapy ...................................................................................... 224
yy yy yy
Chapter V 31: VAntiretroviral VPharmacotherapy....................................................................................... 235
yy yy yy
Chapter V32: VPsychopharmacology Vand VIntegrative VHealth: VCombined VTreatment VofPsychiatric
yy yy yy yy yy yy yy yy
Vand VNeurocognitive V Conditions ........................................................................................................... 247
yy yy yy
Chapter V 33: VPharmacotherapy Vfor VPain VManagement...................................................................... 257
yy yy yy yy yy
Chapter V34: VSubstance VUse VDisorder V III: VHealth VPromotion Vand VMaintenance ........................ 267
yy yy yy yy yy yy yy yy yy
Chapter V35: VOver-the-Counter V Medications ........................................................................................ 283
yy yy yy
Chapter V36: VPharmacotherapy Vfor VObesity ........................................................................................ 291
yy yy yy yy
,Chapter V1: VAn VIntroduction Vto VEvidence-Based VClinical VPractice VGuidelines
yy yy yy yy yy yy yy yy
MULTIPLE VCHOICE yy
• What Vis Vthe Vprimary Vpurpose V of Vthe Vnursing
yy yy yy yy yy yy yy
V assessment? yy
A. Identifying V underlying V pathologic V conditions yy yy yy
B. Assisting V the Vphysician Vin Videntifying Vmedical V conditions yy yy yy yy yy yy
C. Determining V the Vpatients Vmental Vstatus yy yy yy yy
D. Exploring V patient V responses Vto V health V problems yy yy yy yy yy
ANS: VD yy
A Vnursing Vassessment Vis Vdone Vto Videntify Vthe Vpatients Vresponse Vto
yy yy yy yy yy yy yy yy yy yy
Vhealth Vproblems. VDuring Vthe Vnursing Vassessment Vphase, Va
yy yy yy yy yy yy yy yy
Vcomprehensive Vinformation Vbase Vis Vdeveloped Vthrough Va Vphysical
yy yy yy yy yy yy yy yy
Vexamination, Vnursing Vhistory, Vmedication Vhistory, Vand Vprofessional
yy yy yy yy yy yy yy
Vobservation. VIdentifying Vunderlying Vpathologic Vconditions Vand
yy yy yy yy yy yy
Vassisting Vthe Vphysician Vin Videntifying Vmedical Vconditions Vis Vnot
yy yy yy yy yy yy yy yy yy
Vpart Vof Vthe Vnursing Vprocess. VDetermining Vthe Vpatients V mental
yy yy yy yy yy yy yy yy yy
Vstatus
yy V is Vone Vpart V of Vthe
y y V nursing V assessment, V but V it V is
yy yy y y yy y y y y y y y y yy
V not Vthe Vprimary Vpurpose.
y y yy yy yy
DIF: VCognitive VLevel:
yy yy
VComprehension VREF: Vdm V36
yy yy yy yy
VOBJ: V1 V| V3 VTOP: VNursing
yy yy yy yy yy yy
VProcess VStep: VAssessment
yy yy yy
MSC: VNCLEX V Client VNeeds V Category: V Health VPromotion Vand V Maintenance
yy yy yy yy yy yy yy yy
• What Vis Vthe Vbasis Vof Vthe VNANDA VI V taxonomy?
yy yy yy yy yy yy yy yy
A. Functional Vhealth Vpatterns yy yy
B. Human Vresponse Vpatterns yy yy
C. Basic V human V needs yy yy
D. Pathophysiologic V needs yy
ANS: VB yy
The V NANDA V I V taxonomy V identifies V human V response
y y y y y y y y y y y y
V patterns. VFunctional Vcomponents Vof Vhealth Vpatterns Vare Vlimited
y y yy yy yy yy yy yy yy
Vto
yy Vactivity,
yy Vfluid Vvolume, Vnutrition, Vself Vcare, Vand Vsensory
yy yy yy yy yy yy yy
Vperception. VBasic Vhuman Vneeds Vcomprise Vless Vthan Vmerely Vhealth
yy yy yy yy yy yy yy yy yy
Vpatterns.
yy V Pathophysiologic Vneeds V are Vnot Vpart Vof Vthe Vscope Vof
y y yy y y yy yy yy yy yy yy
VNANDA VI.
yy yy
, DIF: VCognitive VLevel: VKnowledge
yy yy yy
VREF: Vpp. V37-38 VOBJ: V5 VTOP:
yy yy yy yy yy yy
Nursing VProcess VStep: VDiagnosis
yy yy yy
MSC: VNCLEX V Client V Needs V Category: VPhysiological V Integrity
yy yy yy yy yy yy
• Which Vtask Vis Vincluded V in Vthe Vassessment Vstep V of Vthe Vnursing
yy yy yy yy yy yy yy yy yy yy y y V process?
A. Establishing V patient yy yy V goals/outcomes
B. Implementing V the V nursing Vcare V plan V (NCP) yy yy yy yy yy
C. Measuring V goal/outcome V achievement yy yy
D. Collecting Vand V communicating V data yy yy yy
ANS: VD yy
Data Vare Vcollected Vand Vcommunicated Vin Vthe Vassessment Vphase Vof
yy yy yy yy yy yy yy yy yy
Vthe Vnursing Vprocess. VEstablishing Vgoals Vis Vthe Vfunction Vof
yy yy yy yy yy yy yy yy yy
Vplanning.
yy
Implementing Vthe VNCP Vis Vthe Vfunction Vof Vimplementation.
yy yy yy yy yy yy yy
VMeasuring Voutcome Vachievement Vis Vthe Vfunction Vof Vevaluation.
yy yy yy yy yy yy yy yy
DIF: VCognitive VLevel:
yy yy
VComprehension VREF: Vdm V36
yy yy yy yy
VOBJ: V2 V| V3 VTOP: VNursing
yy yy yy yy yy yy
VProcess VStep: VAssessment
yy yy yy
MSC: VNCLEX V Client VNeeds V Category: V Health VPromotion Vand V Maintenance
yy yy yy yy yy yy yy yy
• Which Vstatement Vregarding V nursing Vdiagnoses V is
yy yy yy yy yy yy V accurate?
a. Nursing Vdiagnoses Vremain Vthe Vsame V for Vas V long Vas Vthe Vdisease V is
yy yy yy yy yy yy yy yy yy yy yy
V present.
yy
b. Nursing V diagnoses V are Vwritten Vto Videntify Vdisease Vstates.
yy yy yy yy yy yy yy
c. Nursing Vdiagnoses Vdescribe V patient Vproblems Vthat V nurses V treat.
yy yy yy yy yy yy yy
d. Nursing Vdiagnoses V identify Vcauses V related Vto Villness.
yy yy yy yy yy yy
ANS: VC yy
Diagnostic Vstatements Videntify Vproblems Va Vnurse Vis Vindependently
yy yy yy yy yy yy yy
Vable Vto Vtreat Vwithin Vthe Vscope Vof Vprofessional Vpractice. VNursing
yy yy yy yy yy yy yy yy yy yy
Vdiagnoses Vvary Vwith Vthe Vchanging Vcondition Vof Vthe Vpatient. VThe
yy yy yy yy yy yy yy yy yy yy
Vresponse Vpatterns Vare Vunique Vto Vthe Vpatient Vand Vare Vnot Vdisease
yy yy yy yy yy yy yy yy yy yy yy
Vspecific. VNursing Vdiagnoses Vdescribe Vthe Vpatients Vhuman Vresponse
yy yy yy yy yy yy yy yy
Vpattern.
yy
DIF: V Cognitive V Level: V Comprehension
yy yy yy
yy yy yy
PRESCRIBERS 1ST EDITION BY LUO
yy yy yy yy yy
KAYINGO TEST BANK | 2024 UPDATE
yy yy yy yy yy yy
, Table of Contents V
yy V
yy
Chapter V 1: VAn VIntroduction Vto VEvidence-Based VClinical V Practice VGuidelines............................... 3
yy yy yy yy yy yy yy yy
Chapter V2: VPharmacokinetics V /Chapter3: VPharmacodynamics ............................................................. 13
yy yy yy yy
Chapter4: VPharmacogenetics V and VPharmacogenomics .......................................................................... 25
yy yy yy
Chapter V 5: VPharmacology VAcross Vthe VLife VSpan .............................................................................. 30
yy yy yy yy yy yy
Chapter V6: VDrug-Therapy VPrescribing Vin VSpecial VPopulations ......................................................... 36
yy yy yy yy yy yy
Chapter V7: VDrug VDevelopment V and VApproval .................................................................................... 45
yy yy yy yy yy
Chapter V8-Chapter V10: VFoundations Vof VPrescription VWriting VChapter V9: VResponsibleControlled-
yy yy yy yy yy yy yy yy yy
Substance VPrescribing VChapter V10: VAntibiotic VStewardship ................................................................. 51
yy yy yy yy yy
Chapter V11: VApplied VCalculations Vfor V Prescribing ............................................................................ 58
yy yy yy yy yy
Chapter V12-: VPromoting VAdherence VWith VPharmacotherapy VII: VSystem-Specific Vand VPatient-
yy yy yy yy yy yy yy yy yy
Focused VPrescribing VChapter V13: VPharmacotherapy Vfor VEar, VNose, VMouth, VandThroat VConditions
yy yy yy yy yy yy yy yy yy yy
V/Chapter V14: VPharmacotherapy Vfor VEye VConditions ........................................................................... 67
yy yy yy yy yy yy
Chapter V15: VPharmacotherapy Vfor V Skin VConditions .......................................................................... 74
yy yy yy yy yy
Chapter V 16: VPharmacotherapy Vfor V Neurologic V Conditions................................................................ 81
yy yy yy yy yy
Chapter V 17: VPharmacotherapy Vfor V Cardiovascular V Conditions ......................................................... 94
yy yy yy yy yy
Chapter V 18: VPharmacotherapy Vfor V Respiratory VConditions ............................................................. 106
yy yy yy yy yy
Chapter V19: VPharmacotherapy Vfor VGastrointestinal VConditions Vand VConditions
yy yy yy yy yy yy yy
VRequiringNutritional VSupport ................................................................................................................ 117
yy yy
Chapter V 20: VPharmacotherapy Vfor V Genitourinary VConditions.......................................................... 128
yy yy yy yy yy
Chapter V21: VPharmacotherapy Vfor V Renal, VAcid–Base, V Fluid, Vand VElectrolyte VDisorders ......... 133
yy yy yy yy yy yy yy yy yy
Chapter V 22: VPharmacotherapy Vfor VMusculoskeletal Vand VRheumatologic VConditions ................. 146
yy yy yy yy yy yy yy
Chapter V23: VTherapeutic V Applications V of VImmunology Vand VVaccines ....................................... 158
yy yy yy yy yy yy yy
Chapter V 24: VPharmacotherapy Vfor V Endocrine VDisorders ................................................................. 163
yy yy yy yy yy
Chapter V25: VPharmacotherapy Vfor VHematologic VDisorders .............................................................. 174
yy yy yy yy yy
Chapter V 26: VHematology/Oncology Vand VSupportive V Care Vfor Vthe VNononcologist ..................... 190
yy yy yy yy yy yy yy yy
Chapter yy V 27: VPharmacotherapy V Related Vto VWomen’s VHealth VConditions .................................... 196
yy yy yy yy yy yy
Chapter V28: VPharmacotherapy VRelated Vto VMen’s V Health VConditions........................................... 211
yy yy yy yy yy yy yy
Chapter V 29: VPharmacotherapy VRelated Vto VTransgender V Care ....................................................... 217
yy yy yy yy yy yy
Chapter V30: VAntimicrobial VPharmacotherapy ...................................................................................... 224
yy yy yy
Chapter V 31: VAntiretroviral VPharmacotherapy....................................................................................... 235
yy yy yy
Chapter V32: VPsychopharmacology Vand VIntegrative VHealth: VCombined VTreatment VofPsychiatric
yy yy yy yy yy yy yy yy
Vand VNeurocognitive V Conditions ........................................................................................................... 247
yy yy yy
Chapter V 33: VPharmacotherapy Vfor VPain VManagement...................................................................... 257
yy yy yy yy yy
Chapter V34: VSubstance VUse VDisorder V III: VHealth VPromotion Vand VMaintenance ........................ 267
yy yy yy yy yy yy yy yy yy
Chapter V35: VOver-the-Counter V Medications ........................................................................................ 283
yy yy yy
Chapter V36: VPharmacotherapy Vfor VObesity ........................................................................................ 291
yy yy yy yy
,Chapter V1: VAn VIntroduction Vto VEvidence-Based VClinical VPractice VGuidelines
yy yy yy yy yy yy yy yy
MULTIPLE VCHOICE yy
• What Vis Vthe Vprimary Vpurpose V of Vthe Vnursing
yy yy yy yy yy yy yy
V assessment? yy
A. Identifying V underlying V pathologic V conditions yy yy yy
B. Assisting V the Vphysician Vin Videntifying Vmedical V conditions yy yy yy yy yy yy
C. Determining V the Vpatients Vmental Vstatus yy yy yy yy
D. Exploring V patient V responses Vto V health V problems yy yy yy yy yy
ANS: VD yy
A Vnursing Vassessment Vis Vdone Vto Videntify Vthe Vpatients Vresponse Vto
yy yy yy yy yy yy yy yy yy yy
Vhealth Vproblems. VDuring Vthe Vnursing Vassessment Vphase, Va
yy yy yy yy yy yy yy yy
Vcomprehensive Vinformation Vbase Vis Vdeveloped Vthrough Va Vphysical
yy yy yy yy yy yy yy yy
Vexamination, Vnursing Vhistory, Vmedication Vhistory, Vand Vprofessional
yy yy yy yy yy yy yy
Vobservation. VIdentifying Vunderlying Vpathologic Vconditions Vand
yy yy yy yy yy yy
Vassisting Vthe Vphysician Vin Videntifying Vmedical Vconditions Vis Vnot
yy yy yy yy yy yy yy yy yy
Vpart Vof Vthe Vnursing Vprocess. VDetermining Vthe Vpatients V mental
yy yy yy yy yy yy yy yy yy
Vstatus
yy V is Vone Vpart V of Vthe
y y V nursing V assessment, V but V it V is
yy yy y y yy y y y y y y y y yy
V not Vthe Vprimary Vpurpose.
y y yy yy yy
DIF: VCognitive VLevel:
yy yy
VComprehension VREF: Vdm V36
yy yy yy yy
VOBJ: V1 V| V3 VTOP: VNursing
yy yy yy yy yy yy
VProcess VStep: VAssessment
yy yy yy
MSC: VNCLEX V Client VNeeds V Category: V Health VPromotion Vand V Maintenance
yy yy yy yy yy yy yy yy
• What Vis Vthe Vbasis Vof Vthe VNANDA VI V taxonomy?
yy yy yy yy yy yy yy yy
A. Functional Vhealth Vpatterns yy yy
B. Human Vresponse Vpatterns yy yy
C. Basic V human V needs yy yy
D. Pathophysiologic V needs yy
ANS: VB yy
The V NANDA V I V taxonomy V identifies V human V response
y y y y y y y y y y y y
V patterns. VFunctional Vcomponents Vof Vhealth Vpatterns Vare Vlimited
y y yy yy yy yy yy yy yy
Vto
yy Vactivity,
yy Vfluid Vvolume, Vnutrition, Vself Vcare, Vand Vsensory
yy yy yy yy yy yy yy
Vperception. VBasic Vhuman Vneeds Vcomprise Vless Vthan Vmerely Vhealth
yy yy yy yy yy yy yy yy yy
Vpatterns.
yy V Pathophysiologic Vneeds V are Vnot Vpart Vof Vthe Vscope Vof
y y yy y y yy yy yy yy yy yy
VNANDA VI.
yy yy
, DIF: VCognitive VLevel: VKnowledge
yy yy yy
VREF: Vpp. V37-38 VOBJ: V5 VTOP:
yy yy yy yy yy yy
Nursing VProcess VStep: VDiagnosis
yy yy yy
MSC: VNCLEX V Client V Needs V Category: VPhysiological V Integrity
yy yy yy yy yy yy
• Which Vtask Vis Vincluded V in Vthe Vassessment Vstep V of Vthe Vnursing
yy yy yy yy yy yy yy yy yy yy y y V process?
A. Establishing V patient yy yy V goals/outcomes
B. Implementing V the V nursing Vcare V plan V (NCP) yy yy yy yy yy
C. Measuring V goal/outcome V achievement yy yy
D. Collecting Vand V communicating V data yy yy yy
ANS: VD yy
Data Vare Vcollected Vand Vcommunicated Vin Vthe Vassessment Vphase Vof
yy yy yy yy yy yy yy yy yy
Vthe Vnursing Vprocess. VEstablishing Vgoals Vis Vthe Vfunction Vof
yy yy yy yy yy yy yy yy yy
Vplanning.
yy
Implementing Vthe VNCP Vis Vthe Vfunction Vof Vimplementation.
yy yy yy yy yy yy yy
VMeasuring Voutcome Vachievement Vis Vthe Vfunction Vof Vevaluation.
yy yy yy yy yy yy yy yy
DIF: VCognitive VLevel:
yy yy
VComprehension VREF: Vdm V36
yy yy yy yy
VOBJ: V2 V| V3 VTOP: VNursing
yy yy yy yy yy yy
VProcess VStep: VAssessment
yy yy yy
MSC: VNCLEX V Client VNeeds V Category: V Health VPromotion Vand V Maintenance
yy yy yy yy yy yy yy yy
• Which Vstatement Vregarding V nursing Vdiagnoses V is
yy yy yy yy yy yy V accurate?
a. Nursing Vdiagnoses Vremain Vthe Vsame V for Vas V long Vas Vthe Vdisease V is
yy yy yy yy yy yy yy yy yy yy yy
V present.
yy
b. Nursing V diagnoses V are Vwritten Vto Videntify Vdisease Vstates.
yy yy yy yy yy yy yy
c. Nursing Vdiagnoses Vdescribe V patient Vproblems Vthat V nurses V treat.
yy yy yy yy yy yy yy
d. Nursing Vdiagnoses V identify Vcauses V related Vto Villness.
yy yy yy yy yy yy
ANS: VC yy
Diagnostic Vstatements Videntify Vproblems Va Vnurse Vis Vindependently
yy yy yy yy yy yy yy
Vable Vto Vtreat Vwithin Vthe Vscope Vof Vprofessional Vpractice. VNursing
yy yy yy yy yy yy yy yy yy yy
Vdiagnoses Vvary Vwith Vthe Vchanging Vcondition Vof Vthe Vpatient. VThe
yy yy yy yy yy yy yy yy yy yy
Vresponse Vpatterns Vare Vunique Vto Vthe Vpatient Vand Vare Vnot Vdisease
yy yy yy yy yy yy yy yy yy yy yy
Vspecific. VNursing Vdiagnoses Vdescribe Vthe Vpatients Vhuman Vresponse
yy yy yy yy yy yy yy yy
Vpattern.
yy
DIF: V Cognitive V Level: V Comprehension
yy yy yy
